Norekvål, T. M.
Iversen, M. M.
Oterhals, K.
Allore, H.
Borregaard, B.
Pettersen, T. R.
Thompson, D. R.
Zwisler, A. D.
Breivik, K.
Funding for this research was provided by:
University of Bergen
Article History
Received: 1 November 2024
Accepted: 17 March 2025
First Online: 5 April 2025
Declarations
:
: The ethical guidelines of the World Medical Association, Declaration of Helsinki (2008) and the legislation in Norway and Denmark guided the study. At inclusion, a detailed letter informed the potential participant of the study, and the right to withdraw from the study at any time without any reason was underlined. All patients provided informed consent to participate. Data are kept in strict confidence in locked files at research servers to protect the participants’ privacy. Approval by the Norwegian Regional Committee for Ethics in Medical Research in Western Norway was granted (REK 2015/57), and from the Data Protection Agency in the Zealand region for the Danish centres (REG-145-2017). CONCARDPCI was registered at clinicaltrials.gov (NCT03810612) on January 18th 2019.
: Not applicable.
: The authors declare no competing interests.